... Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001, 94 :153-156.2. Non- smallCellLungCancer Collaborative Group: Chemotherapyin nonsmallcelllung cancer: a meta-analysis ... advanced non- small- cell lung cancer: a phase III trial of the European Organiza-tion for Research and Treatment of CancerLung Cancer Group – EORTC 0 897 5. J Clin Oncol 2003, 21: 390 9- 391 7.15. ... in patients withadvanced non- small- celllung cancer. The European Organi-zation for Research and Treatment of CancerLung Cancer Cooperative Group. J Clin Oncol 199 8, 16:2133-2141.7. Crino...
... CA:Clinical dose-volume histogram analysis for pneumonitis after 3Dtreatment for non- smallcelllungcancer (NSCLC). Int J Radiat Oncol BiolPhys 199 9, 45:323-3 29. 25. Kwa SL, Lebesque JV, Theuws JC, ... early-stage non- small- celllung cancer: clinical implications. Radiother Oncol2010, 94 :1-11.27. Chen Y, Guo W, Lu Y, Zou B: Dose-individualized stereotactic bodyradiotherapy for T1-3N0 non- smallcell ... of non- small- cell lung cancer. Int J Radiat Oncol Biol Phys 2002, 52:382-3 89. 16. Qiao X, Tullgren O, Lax I, Sirzén F, Lewensohn R: The role of radiotherapyin treatment of stage I non- small cell...
... body radiotherapy for stage I non- smallcelllung cancer. Radiother Oncol 2007, 85:4 29- 434. 39. Sinha B, McGarry RC: Stereotactic body radiotherapy for bilat-eral primary lung cancers: the Indiana ... Lagerwaard FJ:Critical review of nonsurgical treatment options for stage I non- smallcelllung cancer. Oncologist 2008, 13:3 09- 3 19. 41. Brock J, Ashley S, Bedford J, Nioutsikou E, Partridge M, ... non- smallcell Lung cancer (ROSEL, ClinicalTrials.gov ID = NCT0068 798 6)has been opened for accrual in August 2008. The study isinitiated by the VU medical centre Amsterdam and theDutch Lung Cancer...
... AbstractBackground: To evaluate the performance of surface-based deformable image registration (DR) for adaptive radiotherapy of non- smallcelllungcancer (NSCLC).Methods: Based on 13 patients ... radiotherapy for head-and-neck cancer using anintegrated CT/linear accelerator system. Int J Radiat Oncol BiolPhys 2004, 59: 960 -97 0. 9. Kupelian PA, Ramsey C, Meeks SL, Willough TR, Forbes A, ... parotid glands [8]. Similarfindings were made for non- small- celllung cancer (NSCLC), where a continuous tumor regression duringradiotherapy was observed [9] .This continuous tumor regression during...
... as lung cancer. It is more convenient for the patients and reduces health care costs.This study reports our results on patients with medically inoperable, early stage, non- smallcell lung cancer ... not for citation purposes)Radiation OncologyOpen AccessResearchAbsence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non- smallcelllung cancer Sergio ... 6(page number not for citation purposes)BackgroundThe use of accelerated hypofractionated radiation therapyis an attractive option for patients with early stage non- small celllungcancer (NSCLC)...
... sensitivityoverall 92 %delE746-A750 Ab 63% 22.86% 81.1% 99 % 84.6% 79% l858r Ab 100% 75% 97 % 95 .2% 83%IHC specificityoverall 99 %delE746-A750 Ab 100% 92 % 100% 40% 98 .8%L858R Ab 100% 96 .6% 36% 98 .8%Simonetti ... Non- small- celllungcancer harbouring mutations in the EGFRkinase domain. Clin Transl Oncol 2010, 12:75-80. 9. Gazdar AF: Activating and resistance mutations of EGFR in non- small- cell lung cancer: ... inactivated at 95 °C for 10 min, and the cell extract submitted to PCR. DNAfrom the cell line PC -9 was used as a mutated control for exon 19, and wt control for exons 20 and 21. DNAfrom the H 197 5 cell...
... treatment.IntroductionIn non- smallcelllungcancer (NSCLC), mediastinallymphnode involvement comprises a wide spectrum ofseverity. In fact, while 9% of patients with IIIA-N2NSCLC is candidate for surgery ... Giacomo Carteni’1AbstractBackground: Defining the optimal treatment for patients with inoperable nonsmallcelllungcancer (NSCLC),presenting with metastatic mediastinal lymph nodes, is ... induced byfirst-line chemotherapy with single agentdocetaxel in a patient with advanced non small celllung cancer Ferdinando Riccardi1*, Giuseppe Di Lorenzo1, Carlo Buonerba1, Guglielmo Monaco2,...
... Stereotactic Body Rad iotherapy, Oligometastases, Non- SmallCellLung Cancer Background Non- smallcelllungcancer (NSCLC) is the leadingcause of cancer mortality in the United States [1].Patients ... stage IV non- smallcelllung cancer Praveena Cheruvu1, Su K Metcalfe1, Justin Metcalfe1, Yuhchyau Chen1, Paul Okunieff2and Michael T Milano1*AbstractBackground: Standard therapy for metastatic ... Following liver resection for Hepatic Colorectal Metastases. Annsurg 2002, 235:7 59- 766.13. Sternberg DI, Sonett jr: Surgical Therapy of Lung Metastases. Semin Oncol2007, 133 :96 7 -97 2.Cheruvu et al....
... http://www.ro-journal.com/content/1/1/30Page 9 of 9 (page number not for citation purposes)inoperable non- smallcelllungcancer without mediastinalinvolvement (clinical stage N0, N1). Strahlenther Onkol 199 6,172:4 89- 495 .22. ... N, Saito Y, et al.: Limited field irradiation for medically inoperable patients with peripheral stage I non- smallcelllung cancer. LungCancer 199 9, 26:137-142.23. Slotman BJ, Antonisse IE, ... CentralPage 1 of 9 (page number not for citation purposes)Radiation OncologyOpen AccessResearchStereotactic, single-dose irradiation of stage I non- smallcelllung cancer and lung metastasesPeter...